Premature Ovarian Failure and Ovarian Autoimmunity*
Open accessThe DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Abstract
Premature ovarian failure (POF) is defined as a syndrome characterized by menopause before the age of 40 yr. The patients suffer from anovulation and hypoestrogenism. Approximately 1% of women will experience menopause before the age of 40 yr. POF is a heterogeneous disorder with a multicausal pathogenesis involving chromosomal, genetic, enzymatic, infectious, and iatrogenic causes. There remains, however, a group of POF patients without a known etiology, the so-called "idiopathic" form. An autoimmune etiology is hypothesized for the POF cases with a concomitant Addison's disease and/or oöphoritis. It is concluded in this review that POF in association with adrenal autoimmunity and/or Addison's disease (2-10% of the idiopathic POF patients) is indeed an autoimmune disease. The following evidence warrants this view: 1) The presence of autoantibodies to steroid-producing cells in these patients; 2) The characterization of shared autoantigens between adrenal and ovarian steroid-producing cells; 3) The histological picture of the ovaries of such cases (lymphoplasmacellular infiltrate around steroid-producing cells); 4) The existence of various autoimmune animal models for this syndrome, which underlines the autoimmune nature of the disease. There is some circumstantial evidence for an autoimmune pathogenesis in idiopathic POF patients in the absence of adrenal autoimmunity or Addison's disease. Arguments in support of this are: 1) The presence of cellular immune abnormalities in this POF patient group reminiscent of endocrine autoimmune diseases such as IDDM, Graves' disease, and Addison's disease; 2) The more than normal association with IDDM and myasthenia gravis. Data on the presence of various ovarian autoantibodies and anti-receptor antibodies in these patients are, however, inconclusive and need further evaluation. A strong argument against an autoimmune pathogenesis of POF in these patients is the nearly absent histological confirmation (the presence of an oöphoritis) in these cases (< 3%). However, in animal models using ZP immunization, similar follicular depletion and fibrosis (as in the POF women) can be detected. Accepting the concept that POF is a heterogenous disorder in which some of the idiopathic forms are based on an abnormal self-recognition by the immune system will lead to new approaches in the treatment of infertility of these patients. There are already a few reports on a successful ovulation-inducing treatment of selected POF patients (those with other autoimmune phenomena) with immunomodulating therapies, such as high dosages of corticosteroids (288-292).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Somatic generation of antibody diversity
Tonegawa, S. (1983) · Nature · doi:10.1038/302575a0 · Cited by 4,005
Somatic generation of antibody diversity.
Matthyssens, G., Hozumi, N., & Tonegawa, S. (1976) · PubMed · Cited by 3,244
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Moore, K. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.165 · Cited by 1,884
Cited by
Nelson, L. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0808697 · Cited by 1,158
Premature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 808
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
“presence of ACA and StCA; however, T cell-mediated cytotoxic mechanisms are believed to be involved in the damage of the ovaries (263).”
BackgroundInfluentialGoswami, D., & Conway, G. S. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi012 · Cited by 713
Intraovarian Control of Early Folliculogenesis
Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1020 · Cited by 702
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Primary ovarian insufficiency: a more accurate term for premature ovarian failure
Welt, C. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03073.x · Cited by 538
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 505
Premature menopause in a multi-ethnic population study of the menopause transition
Luborsky, J. L., Meyer, P., Sowers, M. F., Gold, E. B., & Santoro, N. (2003) · Human Reproduction · doi:10.1093/humrep/deg005 · Cited by 423
van Kasteren, Y. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.5.483 · Cited by 404
Macrophage contributions to ovarian function
Wu, R. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh011 · Cited by 386
Stolk, L., Perry, J. R. B., Chasman, D. I., He, C., Mangino, M., Sulem, P., Barbalic, M., Broer, L., Byrne, E. M., Ernst, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.1051 · Cited by 372
Premature Ovarian Insufficiency: Past, Present, and Future
Chon, S. J., Umair, Z., & Yoon, M.-S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672890 · Cited by 366
Premature ovarian failure: an update
Anasti, J. N. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00099-5 · Cited by 337
Premature ovarian insufficiency: an international menopause society white paper
Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., & Wolfman, W. (2020) · Climacteric · doi:10.1080/13697137.2020.1804547 · Cited by 297
Muller, A. F., Drexhage, H. A., & Berghout, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0441 · Cited by 289
Self-citationIshizuka, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626924 · Cited by 262
Jankowska, K. (2017) · Menopausal Review · doi:10.5114/pm.2017.68592 · Cited by 242
“Patients with autoimmune thyroid diseases (Graves’ disease and Hashimoto’s disease) have been shown to have increased amounts of macrophage cells and NK cells with MHC class II molecules (histocompatibility complex class II) in the thyroid gland [19, 20], and increased IgG levels in blood [35, 36].”
BackgroundAutoimmune primary ovarian insufficiency
Silva, C. A., Yamakami, L. Y. S., Aikawa, N. E., Araujo, D. B., Carvalho, J. F., & Bonfá, E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.003 · Cited by 210
“With regard to epidemiology, approximately 1–2% of women will have POI [19,20].”
BackgroundMenopause in Type 1 Diabetic Women
Dorman, J. S., Steenkiste, A. R., Foley, T. P., Strotmeyer, E. S., Burke, J. P., Kuller, L. H., & Kwoh, C. K. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1857 · Cited by 171
Reato, G., Morlin, L., Chen, S., Furmaniak, J., Smith, B. R., Masiero, S., Albergoni, M. P., Cervato, S., Zanchetta, R., & Betterle, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0414 · Cited by 118
“Furthermore, there is a close correlation between the presence of StCA and a lymphocytic infiltration of the ovarian tissue (12).”
BackgroundFactors associated with age of onset and type of menopause in a cohort of UK women
Pokoradi, A. J., Iversen, L., & Hannaford, P. C. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.059 · Cited by 87
The effect of endometriosis on the antimüllerian hormone level in the infertile population
Romanski, P. A., Brady, P. C., Farland, L. V., Thomas, A. M., & Hornstein, M. D. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01450-9 · Cited by 49
Screening for associated autoimmune disorders in Polish patients with Addison’s disease
Fichna, M., Fichna, P., Gryczyńska, M., Walkowiak, J., Żurawek, M., & Sowiński, J. (2010) · Endocrine · doi:10.1007/s12020-010-9312-x · Cited by 47
Artunc-Ulkumen, B., Pala, H. G., Pala, E. E., Yavasoglu, A., Yigitturk, G., & Erbas, O. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975686 · Cited by 45
“menopause have concominant autoimmune disease [7].”
Falorni, A., Brozzetti, A., Aglietti, M. C., Esposito, R., Minarelli, V., Morelli, S., Sbroma Tomaro, E., & Marzotti, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04387.x · Cited by 25
Metadata
- Authors
- Hoek, A., Schoemaker, J., & Drexhage, H. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1997-02-01
- Volume
- 18
- Issue
- 1
- Pages
- 107-134
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2152847118
- Cited by
- 439
- References
- 186
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.